Public Profile

Virbac France SAS

Virbac France SAS, a leading player in the veterinary pharmaceutical industry, is headquartered in France and operates extensively across Europe, Asia, and the Americas. Founded in 1968, Virbac has established itself as a trusted provider of innovative health solutions for pets and livestock, focusing on areas such as vaccines, anti-infectives, and dermatology. With a commitment to research and development, Virbac offers a unique range of products that cater to the specific needs of animals, ensuring their health and well-being. The company has achieved significant milestones, including a strong market position as one of the top global veterinary pharmaceutical firms. Virbac's dedication to quality and innovation continues to set it apart in the competitive landscape of animal health.

DitchCarbon Score

How does Virbac France SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Virbac France SAS's score of 26 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Virbac France SAS's reported carbon emissions

Virbac France SAS currently does not have publicly available carbon emissions data or specific reduction targets. As a company operating in the veterinary pharmaceutical industry, Virbac is likely aware of the growing importance of sustainability and climate commitments. While no specific initiatives or targets have been disclosed, the industry is increasingly focusing on reducing carbon footprints and enhancing environmental responsibility. Virbac may be exploring strategies to align with global climate goals, but further information is needed to detail their specific commitments or achievements in this area.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Virbac France SAS's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Virbac France SAS is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Virbac France SAS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Ceva Sante Animale

FR
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Elanco

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Huvepharma N.V.

NL
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers